Company profile for Vivera Pharmaceuticals

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Vivera Pharmaceuticals, Inc. is an innovative, science-driven pharmaceutical company focused on opioid deterrence and cessation and non-addictive solutions for pain management. In addition to its pharmaceutical and medical device products, the Company has global exclusivity to license the patented and provisionally patented, TABMELT® sublingual drug-delivery system for pharmaceutical use. Vivera Pharmaceuticals is seeking to ...
Vivera Pharmaceuticals, Inc. is an innovative, science-driven pharmaceutical company focused on opioid deterrence and cessation and non-addictive solutions for pain management. In addition to its pharmaceutical and medical device products, the Company has global exclusivity to license the patented and provisionally patented, TABMELT® sublingual drug-delivery system for pharmaceutical use. Vivera Pharmaceuticals is seeking to conduct case studies and clinical trials utilizing the TABMELT drug delivery format. Vivera is vertically integrated with patented technology, manufacturing capabilities, and distribution for its products.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
4533 MacArthur Blvd 5049 Newport Beach, California 92660
Telephone
Telephone
1.844.484.8372
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.accesswire.com/viewarticle.aspx?id=796157&lang=en

ACCESSWIRE
26 Oct 2023

https://www.prnewswire.com/news-releases/vivera-welcomes-former-fda-investigator-dennis-moore-as-regulatory-and-compliance-advisor-301746304.html

PR NEWSWIRE
14 Feb 2023

https://www.prnewswire.com/news-releases/vivera-expands-tabmelt-global-licensing-reach-with-grant-of-israel-patent-301714172.html

PR NEWSWIRE
05 Jan 2023

https://www.prnewswire.com/news-releases/vivera-welcomes-seasoned-publicist-amanda-whitcroft-as-director-of-public-relations-301696691.html

PRNEWSWIRE
07 Dec 2022

http://pharmabiz.com/NewsDetails.aspx?aid=154106&sid=2

PHARMABIZ
29 Oct 2022

https://www.prnewswire.com/news-releases/vivera-enters-6b-market-with-speech-assessment-and-feedback-device-patent-allowance-301658035.html

PRNEWSWIRE
25 Oct 2022

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty